David Raben

Chief Medical Officer · Bicara Therapeutics

David Raben (Chief Medical Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $302K of BCAX (16,300 sh × $18.52, as filed), executed Mar 4. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$532K

shares × price, as filed

Last traded

Apr 27

Filed Apr 28

Median ADV $19.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

BCAX

Bicara Therapeutics Inc. BCAX · 0 buys · 5 sells 5 filings

Recent filings

BCAXSALE Bicara Therapeutics Inc. View filing → $126K
5,500 sh × $22.88
Exec Apr 27
Filed Apr 28 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $104K
5,500 sh × $18.95
Exec Mar 25
Filed Mar 26 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $302K
16,300 sh × $18.52
Exec Mar 4
Filed Mar 5 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $101K
5,500 sh × $18.45
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $406K
22,000 sh × $18.45
Exec Oct 9 2025
Filed Oct 10 2025 · 5:30 PM ET